Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
about
Echocardiographic assessment for ventricular assist device placementChronic inotropic therapy in end-stage heart failure.Towards non-thrombogenic performance of blood recirculating devicesEarly adverse events as predictors of 1-year mortality during mechanical circulatory support.Initial in vivo evaluation of the DexAide right ventricular assist device.The potential for the use of nanofeaturing in medical devices.Perioperative management of patients with poorly functioning ventricles in the setting of the functionally univentricular heart.Device thrombogenicity emulation: a novel methodology for optimizing the thromboresistance of cardiovascular devicesFrom cardiac repair to cardiac regeneration--ready to translate?Quality of life assessment in heart failure interventions: a 10-year (1996-2005) review.Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries.Cost-effectiveness of left ventricular-assist devices in end-stage heart failure.Advances in the surgical treatment of heart failure.Surface coatings for ventricular assist devices.Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation.Right ventricular dysfunction during intensive pharmacologic unloading persists after mechanical unloading.Heart failure in the elderly: advances and challenges.Pharmacologic therapy for New York Heart Association class IV heart failure.Sarcoplasmic reticulum and calcium cycling targeting by gene therapy.Refractory heart failure dependent on short-term mechanical circulatory support: what next? Heart transplant or long-term ventricular assist device.Current status of third-generation implantable left ventricular assist devices in Japan, Duraheart and HeartWare.Clinical Issues and Controversies in Heart Failure and Transplantation.Nonadherence in the Advanced Heart Failure Population.Neprilysin inhibition: A brief review of past pharmacological strategies for heart failure treatment and future directions.HeartWare-HVAD for end-stage heart failure: a review of clinical experiences with ≥50 patients.Development of bioartificial myocardium using stem cells and nanobiotechnology templates.Outcomes of ventricular assist device implantation in children and young adults: the Melbourne experience.Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.A fluid dynamics study in a 50 cc pulsatile ventricular assist device: influence of heart rate variabilityThe effectiveness of cardiac resynchronization therapy for patients with New York Heart Association class IV non-ambulatory heart failure.Heart and lung transplantation in the United States, 1996-2005.Association between conformity with performance measures and 1-year postdischarge survival in patients with acute decompensated heart failure.Defining Ambulatory Advanced Heart Failure: MedaMACS and Beyond.The Initial Evaluation and Management of a Patient with Heart Failure.A sliding mode-based starling-like controller for implantable rotary blood pumps.Current indications for transplantation: stratification of severe heart failure and shared decision-making.Thoracic organ transplantation in the United States, 1995-2004.Intravenous inotropic agents in heart failure.
P2860
Q26770295-4F49DA9B-15EC-4201-A04D-F1127C6DDE7EQ33735360-6E755C5B-3962-4915-9B45-1552601D2618Q33822427-515DA2E6-52AE-4A1F-A441-55225B373187Q34079591-122D324D-1636-4F62-965D-C20082E0F4C7Q34343157-F182AAC6-8ED7-45EA-8292-15D51CA20DC0Q36313281-FDD40180-DE36-48F4-88A7-29C4DD503E0FQ36364102-34D5ABC7-2034-4DFB-9818-A53350BB33EAQ36553424-7E796F24-5FEC-4B6F-90DF-063CF61656FFQ36569726-55F1B609-7CFA-4138-9B67-16DA965736A2Q36966553-14D8C81C-56BE-4DEF-82F6-524DB3F89EE3Q37067918-17C58580-985B-46F0-9DF3-8319305FE127Q37076282-17BBFA06-8DD9-4892-A042-9240E4FEAE80Q37125787-E5E5F172-BBA3-4D08-9A2D-C3B686E49BD7Q37357350-50A887E8-9002-498B-A1B9-3CBAB35BA067Q37390760-F288264F-CEAE-4BC6-8C57-D88BCF3C1856Q37552482-AF085913-6351-4369-8837-00124B0E50D6Q37744960-CB84A366-A1E6-48E2-A694-22BD12DAEC71Q37929864-412A2CDD-1200-4FE6-B789-34D9AB0419C9Q38016716-D74CF1C4-BDFA-4752-932B-D52DB53E10FCQ38131850-F57F0F22-F418-42C3-A5AF-E0AF7BAEE4E0Q38241428-679C67CF-6949-4517-9446-E56C72B1D646Q38682429-D5681F64-8773-46F6-AAC2-DCB94CF2294CQ38734545-CE533D90-1C9B-4D5F-BCDA-172C25CF6AFEQ38817943-AA1C3343-1824-4929-BB5D-9580F6C14536Q39280352-E44FF33A-8372-4A90-91CF-F39505A1A791Q39791530-2B8335D0-F006-4C87-98FC-461F87BBF1F2Q41092340-E0711BFC-DDC8-4F16-AFA8-9887B80AE20EQ41308190-2D9393D4-5E1D-4CEE-B190-E87C336F93F1Q42289916-7706FE7D-0179-4547-8FFE-8CF424669A40Q43009514-600ADB52-DE75-490E-9ED3-C3D2BCEAD21EQ44301993-4426ED6E-C4AF-4134-8EB4-EFF65B519E58Q47354674-465B6F42-B20D-45F0-ADD2-A190496299F4Q47550657-97F30ED4-19D8-42DC-A7BA-77E61AA594B5Q47552207-48830072-6376-49CF-B863-E797E955AB2AQ48703255-7EECA459-F295-4527-B806-ECFB79161050Q50332202-CA12B3B5-2A56-4037-9CA9-ECFA391F5F86Q53249378-FADCDD41-048E-41EF-9E20-6FB68D71DF6DQ54029634-F16FF173-4798-4AD9-9E68-33D68D351B95
P2860
Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Left ventricular assist device ...... ent of Chronic Heart Failure).
@en
type
label
Left ventricular assist device ...... ent of Chronic Heart Failure).
@en
prefLabel
Left ventricular assist device ...... ent of Chronic Heart Failure).
@en
P2093
P1433
P1476
Left ventricular assist device ...... ent of Chronic Heart Failure).
@en
P2093
Dale G Renlund
Deborah D Ascheim
Donna Mancini
L Samuel Wann
Leslie W Miller
Lynne Warner Stevenson
Maria Rosa Costanzo
Michael K Parides
Patrice Desvigne-Nickens
REMATCH Investigators
P304
P356
10.1161/01.CIR.0000139862.48167.23
P407
P577
2004-08-16T00:00:00Z